Health and Healthcare
5864 Articles
Dendreon Corp. (NASDAQ: DNDN) has already been all over the news with its positive PROVENGE data for the submission of…
Story UPDATED at 3:10 EST: 15:05:01 EST NASDAQ has reviewed the transactions under rule 11890 (b) on its own motion…
Dendreon Corporation (NASDAQ: DNDN) was halted today at 13:27:02 ahead of the data embargo due at 2:00 PM EST. The…
The Tickerspy index of swine flu and bird flu stocks is up 21% as the market nears its close. The…
Using stock options in Dendreon Corp. (NASDAQ: DNDN) shows that the expectations of major price moves have not let up,…
You have probably heard more and more about the swine flu epidemic from Mexico spreading to the U.S., and a…
Amgen Inc. (NASDAQ: AMGN) has posted some very highly anticipated and uninteresting earnings. The biotech giant reported $0.98 EPS net…
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association…
Dendreon Corporation (NASDAQ: DNDN) has announced that its pivotal Phase 3 IMPACT study of PROVENGE in men with advanced prostate…
About two years ago, GE (GE) began to talk about its “green” initiative and how important it was that businesses…
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is taking it right on the chin this morning. The company announced that it has…
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is getting shelled this morning. The company released “positive study data” this morning on trials…
Osiris Therapeutics, Inc. (NASDAQ: OSIR) is seeing its stock getting pounded this morning. The company announced that it was ending…
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover…
The hope for a higher Genentech Inc. (NYSE: DNA) buyout price is getting smaller and smaller. After the companies agreed…
Our top personal finance-related articles today. Your wallet will thank you later.